The high prevalence of HPV in addition to the causal association to cervical cancer has led to the development of Gardasil, a prophylactic vaccine that that helps protect against four types of human papillomavirus: two types that cause 70% of cervical cancer cases (HPV16 and 18), and two more types (HPV 6 and 11) that cause 90% of genital warts cases (Pallecaros & Vonau, 541). In
The high prevalence of HPV in addition to the causal association to cervical cancer has led to the development of Gardasil, a prophylactic vaccine that that helps protect against four types of human papillomavirus: two types that cause 70% of cervical cancer cases (HPV16 and 18), and two more types (HPV 6 and 11) that cause 90% of genital warts cases (Pallecaros & Vonau, 541). In